Keyphrases
Alloimmune Response
16%
Antithrombotic Activity
16%
Autologous Transplantation
16%
Cell Adhesion
16%
Cell Infiltration
16%
Clinical Application
16%
Clinical Development
16%
Coagulation
16%
Complement Deposition
16%
Complement Inhibition
33%
Complement Inhibitors
100%
Complement System
16%
Composite Graft
16%
Differential Use
16%
Druggable Targets
16%
Dual Function
16%
Graft Survival
16%
Hindlimb
100%
Hindlimb Ischemia
33%
Inflammatory Conditions
16%
Injury Model
16%
Ischemia-reperfusion Injury
50%
Microvascular Composites
16%
Murine Model
100%
Myeloid Cells
16%
Non-blocking
16%
P-selectin
100%
Thrombotic
16%
Tissue Perfusion
16%
Transplantation
100%
Vascular Injury
16%
Vascularized Composite Allograft
16%
Medicine and Dentistry
Allograft
16%
Antithrombotic Activity
16%
Blood Vessel Injury
16%
Cell Adhesion
16%
Cellular Infiltration
16%
Complement Deposition
16%
Complement Inhibition
33%
Complement Inhibitor
100%
Complement System
16%
Composite Graft
33%
Diseases
16%
Graft Survival
16%
Hindlimb
100%
Immunosuppressive Drug
16%
In Vitro
16%
Myeloid Cell
16%
PADGEM Protein
100%
Reperfusion Injury
50%
Serositis
16%
Immunology and Microbiology
Allograft
16%
Cell Adhesion
16%
Cell Infiltration
16%
Complement Deposition
16%
Complement Inhibition
33%
Complement Inhibitor
100%
Complement System
16%
Immunosuppressive Drug
16%
Myeloid
16%
P-Selectin
100%
Reperfusion
50%
Tissue Perfusion
16%